Palbociclib (Ibrance)

[ ANTI-CANCER DRUGS ]
UNIT PRICE: 3,299.00 USD
  3,299.00 USD
In Stock

Palbociclib (PD-0332991, trade name Ibrance)

Related Products

Product Details

Its a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6
VIEW ALL PRODUCTS